
However at such concentration, it will cause greater toxicity to bodily tissues. At much higher concentration, there is more T2 shortening effect of gadolinium, causing gadolinium brightness to be less than surrounding body tissues. Higher concentrations are often used for finer vasculature. For large vessels such as the aorta and its branches, the dose can be as low as 0.1 mmol / kg of body mass. Over 450 million doses have been administrated worldwide from 1988 to 2017. Gadolinium(III) containing MRI contrast agents (often termed simply "gado" or "gad") are the most commonly used for enhancement of vessels in MR angiography or for brain tumor enhancement associated with the degradation of the blood–brain barrier. T 1-weighted images, left image without, right image with contrast medium administration Responsive (smart or bioactivated) agentsĮffect of contrast agent on images: Defect of the blood–brain barrier after stroke shown in MRI.Active targeting/cell labeling agents (tumor-specific agents).Organ specific agents (gastrointestinal contrast agents and hepatobiliary contrast agents).Blood pool agents ( intravascular contrast agents).Extracellular fluid agents (intravenous contrast agents).MRI contrast agents can be classified by their: tract scans, while intravascular administration proves more useful for most other scans. Oral administration is well suited to G.I. MRI contrast agents may be administered by injection into the blood stream or orally, depending on the subject of interest. The systematic sampling of this polarization over the spatial region of the tissue being examined forms the basis for construction of the image. Thermally driven motion of the strongly paramagnetic metal ions in the contrast agent generate the oscillating magnetic fields that provide the relaxation mechanisms that enhance the rate of decay of the induced polarization. Most clinically used MRI contrast agents work by shortening the T1 relaxation time of protons inside tissues via interactions with the nearby contrast agent. A contrast agent usually shortens, but in some instances increases, the value of T1 of nearby water protons thereby altering the contrast in the image. Water protons in different tissues have different T1 values, which is one of the main sources of contrast in MR images. The magnitude of the spin polarization detected by the receiver is used to form the MR image but decays with a characteristic time constant known as the T1 relaxation time. Random molecular rotational oscillations matching the resonance frequency of the nuclear spins provide the "relaxation" mechanisms that bring the net magnetization back to its equilibrium position in alignment with the applied magnetic field. An intense radiofrequency pulse is applied that tips the magnetization generated by the hydrogen nuclei in the direction of the receiver coil where the spin polarization can be detected.

In MRI scanners, sections of the body are exposed to a strong magnetic field causing primarily the hydrogen nuclei ("spins") of water in tissues to be polarized in the direction of the magnetic field. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration. The most commonly used compounds for contrast enhancement are gadolinium-based. MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). Types of contrast agents used for magnetic resonance imaging
